Skip to content

Clinical trials

Phase 1 Osteoporosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 1 Country / region: United States Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20032
20041
20052
20064
20074
20085
20092
20112
20121
20132
20153
20161
20202
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Withdrawn2
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
University of Pittsburgh5
Amgen3
Warner Chilcott3
Duquesne University2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Purdue University2
Radius Health, Inc.2
University of Connecticut2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis39
Bone Diseases, Metabolic7
Endocrine System Diseases5
Musculoskeletal Diseases5
Osteoporosis, Postmenopausal4
Hyperparathyroidism3
Bone Diseases, Endocrine2
Bone Resorption2
Cardiovascular Diseases2
Anxiety Disorders1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.